Intelligence Unit Special Reports Special Events Subscribe Sponsored Departments Follow Us

Twitter Facebook LinkedIn RSS

Drug Firm to Pay Feds $280 Million to Settle Pricing Claims

In a whistleblower suit, the U.S. Justice Department accused Dey Pharma  of violating the False Claims Act by artificially inflating prices for drugs reimbursed with federal funds.

Please enter your comment below:
Please enter the text below: